(Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies for multiple neuroinflammatory diseases that impact nearly 10 million people worldwide, ...

Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies for multiple neuroinflammatory ...

Health and space experts are warning that even a brief glance at the event without proper protection could cause permanent damage.

A pivotal trial is now underway for i-Lumen AMD, a bioelectric therapy being investigated for intermediate to advanced dry ...

Kodiak Sciences KOD announced that it initiated a global late-stage ALTO study evaluating KSI-501 in patients with diabetic ...

In 2017, a woman suffered severe vision impairment after gazing at a partial solar eclipse without protective eyewear. This led to solar retinopathy, manifesting as a crescent-shaped blind spot.

On the afternoon of 21 August 2017, millions of people across the United States looked towards the Sun as the Moon moved across it. For most viewers, the eclipse became a short-lived memory once the ...

A Gemini-powered medical AI combined sight, sound, and clinical reasoning to match or outperform physicians on key measures in simulated video consultations, while revealing where human connection and ...

We report a novel surgical approach for managing late hypotony in PreserFlo MicroShunt blebs. Hypotony is a well-known ...

New research challenges the dodo's long-held reputation for foolishness. Scientists used CT scans and digital brain ...

Annexon, Inc. ( ANNX) Q2 2026 Earnings Call August 12, 2026 8:00 AM EDT ...